Surrey researchers Sign in
Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer
Conference presentation   Open access  Peer reviewed

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

GR Simpson, A Horvath, K Harrington, RS Coffin and H Pandha
EJC SUPPLEMENTS, Vol.6(12), pp.97-98
20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (Geneva, SWITZERLAND, 21/10/2008 - 24/10/2008)
01/10/2008

Abstract

Science & Technology Life Sciences & Biomedicine Oncology Microbial and Cellular Sciences
tif
FIG 6 LARGE12.51 MBDownloadView
Image Open Access
doc
bladder_paper_bjc144.50 kBDownloadView
Text Open Access
doc
table 136.00 kBDownloadView
Text Open Access
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000261221200303&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

156 File views/ downloads
35 Record Views

Details

Usage Policy